These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8262182)

  • 1. Hydrolysis of small peptide substrates parallels binding of chymotrypsin inhibitor 2 for mutants of subtilisin BPN'.
    Eder J; Rheinnecker M; Fersht AR
    FEBS Lett; 1993 Dec; 335(3):349-52. PubMed ID: 8262182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding, proteolytic, and crystallographic analyses of mutations at the protease-inhibitor interface of the subtilisin BPN'/chymotrypsin inhibitor 2 complex.
    Radisky ES; Kwan G; Karen Lu CJ; Koshland DE
    Biochemistry; 2004 Nov; 43(43):13648-56. PubMed ID: 15504027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant chymotrypsin inhibitor 2: expression, kinetic analysis of inhibition with alpha-chymotrypsin and wild-type and mutant subtilisin BPN', and protein engineering to investigate inhibitory specificity and mechanism.
    Longstaff C; Campbell AF; Fersht AR
    Biochemistry; 1990 Aug; 29(31):7339-47. PubMed ID: 2207109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new substrate and two inhibitors applicable for thermitase, subtilisin BPN' and alpha-chymotrypsin. Comparison of kinetic parameters with customary substrates and inhibitors.
    Brömme D; Fittkau S
    Biomed Biochim Acta; 1985; 44(7-8):1089-94. PubMed ID: 3910035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of residues in the reactive site loop of chymotrypsin inhibitor 2 to protein stability and activity.
    Jackson SE; Fersht AR
    Biochemistry; 1994 Nov; 33(46):13880-7. PubMed ID: 7947796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of subtilisin BPN' by reaction site P1 mutants of Streptomyces subtilisin inhibitor.
    Kojima S; Nishiyama Y; Kumagai I; Miura K
    J Biochem; 1991 Mar; 109(3):377-82. PubMed ID: 1908859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of a stabilizing Ca(2+)-binding loop into subtilisin BPN'.
    Braxton S; Wells JA
    Biochemistry; 1992 Sep; 31(34):7796-801. PubMed ID: 1510966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subtilisin BPN' variants: increased hydrolytic activity on surface-bound substrates via decreased surface activity.
    Brode PF; Erwin CR; Rauch DS; Barnett BL; Armpriester JM; Wang ES; Rubingh DN
    Biochemistry; 1996 Mar; 35(10):3162-9. PubMed ID: 8605150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing subtilisin BPN' to cleave substrates containing dibasic residues.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1995 Oct; 34(41):13312-9. PubMed ID: 7577915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering a novel specificity in subtilisin BPN'.
    Rheinnecker M; Baker G; Eder J; Fersht AR
    Biochemistry; 1993 Feb; 32(5):1199-203. PubMed ID: 8448130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Furilisin: a variant of subtilisin BPN' engineered for cleaving tribasic substrates.
    Ballinger MD; Tom J; Wells JA
    Biochemistry; 1996 Oct; 35(42):13579-85. PubMed ID: 8885837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of a small peptide-based proteinase inhibitor by modeling the active-site region of barley chymotrypsin inhibitor 2.
    Leatherbarrow RJ; Salacinski HJ
    Biochemistry; 1991 Nov; 30(44):10717-21. PubMed ID: 1931991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the mechanism and improving the rate of substrate-assisted catalysis in subtilisin BPN'.
    Carter P; Abrahmsén L; Wells JA
    Biochemistry; 1991 Jun; 30(25):6142-8. PubMed ID: 2059622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetic specificities of BPN' and Carlsberg subtilisins. Mapping the aromatic binding site.
    Karasaki Y; Ohno M
    J Biochem; 1978 Sep; 84(3):531-8. PubMed ID: 102640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variants of subtilisin BPN' with altered specificity profiles.
    Rheinnecker M; Eder J; Pandey PS; Fersht AR
    Biochemistry; 1994 Jan; 33(1):221-5. PubMed ID: 8286344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free energy perturbation calculations on binding and catalysis after mutating threonine 220 in subtilisin.
    Mizushima N; Spellmeyer D; Hirono S; Pearlman D; Kollman P
    J Biol Chem; 1991 Jun; 266(18):11801-9. PubMed ID: 1904871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of amino acid residues responsible for the changes of absorption and fluorescence spectra on the binding of subtilisin BPN' and Streptomyces subtilisin inhibitor.
    Masuda-Momma K; Shimakawa T; Inouye K; Hiromi K; Kojima S; Kumagai I; Miura K; Tonomura B
    J Biochem; 1993 Dec; 114(6):906-11. PubMed ID: 8138550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extensive comparison of the substrate preferences of two subtilisins as determined with peptide substrates which are based on the principle of intramolecular quenching.
    Grøn H; Meldal M; Breddam K
    Biochemistry; 1992 Jul; 31(26):6011-8. PubMed ID: 1627543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enzyme-substrate interactions in the hydrolysis of peptide substrates by thermitase, subtilisin BPN', and proteinase K.
    Brömme D; Peters K; Fink S; Fittkau S
    Arch Biochem Biophys; 1986 Feb; 244(2):439-46. PubMed ID: 3511847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel peptide inhibitor of subtilisin BPN'.
    Ishida K; Shimizu M; Wakasugi A; Matsui Y; Nakamura A; Kojima S
    FEBS Open Bio; 2022 Nov; 12(11):2057-2064. PubMed ID: 36053920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.